Advances in Non-Invasive Electrocardiographic Monitoring Techniques Book

	Contributors List
	Preface
	Introduction
Ch. 1	Physiology and Pathophysiology
Sect. 1	Basic Research: From Gene to Phenotype	1
	Cardiovascular molecular genetics	3
	Dilated cardiomyopathy and arrhythmogenic right ventricular dysplasia: From gene to phenotype	19
	Heart failure: From gene to therapy	27
Sect. 2	Autonomic Nervous System	39
	Autonomic Nervous System: Physiology and pathophysiology	41
	Methods to assess baroreflex sensitivity as a measure of the activity of the autonomic nervous system	51
	Role of the Autonomic Nervous System in cardiovascular diseases	59
	Therapeutical options to influence the autonomic nervous system	69
Ch. 2	ECG aspects investigated by different methods
Sect. 1	P-wave and QRS	87
	The signal averaged P-wave	89
	Wenckebach pattern of ventricular late potentials	99
	Detection of QRS-variability	109
Sect. 2	QT-variability/QT dispersion	121
	QT-Dispersion: Role in clinical decision making	123
	Dynamic QT-interval analysis	131
	QT-variability: Clinical results and prognostic significance	143
	Heart rate dependency of QT-Interval in congenital and acquired prolonged ventricular repolarisation: Long-term analysis by Holter Monitoring	155
Sect. 3	T-wave alternans / repolarization	161
	Modern approaches to assessment of ventricular repolarisation	163
	Dynamicity of T-wave alternans: Measurement and role in sudden death	177
	Macrovolt T-wave alternans: pathophysiology and link with repolarization-dispersion	191
	T-wave alternans and variability: prognostic, diagnostic and therapeutic implications	201
Ch. 3	Focus on: Ischemic Heart Disease	209
	Non-invasive quantification / localisation of myocardial ischemia	211
	Ambulatory ECG, myocardial ischemia and risk stratification	217
	Post thrombolysis / post PTCA-monitoring	223
	Interactive Holter-monitoring of transient ischemic episodes	233
	Silent ischemia: The 1998 status: new observations on triggers, pathophysiological mechanisms and circadian variations	239
	Circadian variation in myocardial ischemia and infarction	247
	Chronopharmacology - Implications for diagnosis and treatment	263
	Beta blockers following acute myocardial infarction	279
	The United States Multicenter Study of enhanced external counterpulsation (MUST-EECP)	283
Ch. 4	Methods
Sect. 1	Quality control and standardization of monitoring techniques	287
	Heart rate variability: A simple methodology with several unrecognized technical and methodological problems	289
	Quality control and standardization: High resolution ECG	297
Sect. 2	Exercise ECG	303
	Diagnosis of myocardial viability: Contribution of the ECG	305
	Exercise testing for risk stratification	317
	Cardiopulmonary exercise testing: cardiovascular and respiratory limitations detected by exercise gas exchange	331
Sect. 3	Ambulatory Blood Pressure Monitoring	341
	White-coat hypertension: State of the art	343
	Should antihypertensive treatment by guided by casual measurement or through Ambultory Blood Pressure Monitoring	351
	Non-invasive pulse wave velocity as a method to evaluate physical properties of the large arteries in aging and hypertension	359
	Prognostic implications of blood pressure variability	371
Sect. 4	Magnetocardiography	381
	Magnetocardiographic technology: State of the art	383
	Ischemia and hibernation in magnetocardiography	393
	MCG at the turn of the millenium	401
Ch. 5	Analysis Techniques
Sect. 1	Non-linear dynamics	411
	Methods of non-linear dynamics	413
	Heart rate variability and non-linear dynamics	421
	Symbolic dynamics	429
Sect. 2	Newer signal detection and analysis techniques	439
	Neural classification in high-resolution ECG signal processing	441
	Cardiovascular system identification	453
	Maximum likelihood analysis in ECG signal processing	463
	What can cardiac computer models tell us about arrhythmogenesis	471
	Index	481